首页 > 最新文献

Journal of immunological methods最新文献

英文 中文
Isolation of anti-Ancylostoma-secreted protein 5 (ASP5) antibody from a naïve antibody phage library. 从幼稚抗体噬菌体文库中分离抗肺泡瘤分泌蛋白 5 (ASP5) 抗体。
IF 1.6 4区 医学 Q4 BIOCHEMICAL RESEARCH METHODS Pub Date : 2024-11-15 DOI: 10.1016/j.jim.2024.113776
Brenda Pei Chui Song, Jing Yi Lai, Yee Siew Choong, Nafiseh Khanbabaei, Andreas Latz, Theam Soon Lim

Ancylostoma species are parasitic nematodes that release a multitude of proteins to manipulate host immune responses to facilitate their survival. Among the released proteins, Ancylostoma-secreted protein 5 (ASP5) plays a pivotal role in mediating host-parasite interactions, making it a promising target for interventions against canine hookworm infections caused by Ancylostoma species. Antibody phage display, a widely used method for generating human monoclonal antibodies was employed in this study. A bacterial expression system was used to produce ASP5 for biopanning. A single-chain fragment variable (scFv) monoclonal antibody against ASP5 was generated from the naïve Human AntibodY LibrarY (HAYLY). The resulting scFv antibody was characterized to elucidate its antigen-binding properties. The identified monoclonal antibody showed good specificity and binding characteristics which highlighting its potential for diagnostic applications in combating hookworm infections.

子囊梭菌是一种寄生线虫,会释放多种蛋白质来操纵宿主的免疫反应,以促进其生存。在这些释放的蛋白质中,疟原虫分泌蛋白5(ASP5)在介导宿主与寄生虫之间的相互作用中发挥着关键作用,因此成为干预由疟原虫引起的犬钩虫感染的一个很有前景的靶点。抗体噬菌体展示是一种广泛用于生成人类单克隆抗体的方法,本研究采用了这种方法。细菌表达系统用于生产 ASP5,以进行生物扫描。从原始人类抗体库(HAYLY)中生成了针对 ASP5 的单链片段可变(scFv)单克隆抗体。对产生的 scFv 抗体进行了表征,以阐明其抗原结合特性。鉴定出的单克隆抗体显示出良好的特异性和结合特性,突出了其在抗钩虫感染诊断应用中的潜力。
{"title":"Isolation of anti-Ancylostoma-secreted protein 5 (ASP5) antibody from a naïve antibody phage library.","authors":"Brenda Pei Chui Song, Jing Yi Lai, Yee Siew Choong, Nafiseh Khanbabaei, Andreas Latz, Theam Soon Lim","doi":"10.1016/j.jim.2024.113776","DOIUrl":"https://doi.org/10.1016/j.jim.2024.113776","url":null,"abstract":"<p><p>Ancylostoma species are parasitic nematodes that release a multitude of proteins to manipulate host immune responses to facilitate their survival. Among the released proteins, Ancylostoma-secreted protein 5 (ASP5) plays a pivotal role in mediating host-parasite interactions, making it a promising target for interventions against canine hookworm infections caused by Ancylostoma species. Antibody phage display, a widely used method for generating human monoclonal antibodies was employed in this study. A bacterial expression system was used to produce ASP5 for biopanning. A single-chain fragment variable (scFv) monoclonal antibody against ASP5 was generated from the naïve Human AntibodY LibrarY (HAYLY). The resulting scFv antibody was characterized to elucidate its antigen-binding properties. The identified monoclonal antibody showed good specificity and binding characteristics which highlighting its potential for diagnostic applications in combating hookworm infections.</p>","PeriodicalId":16000,"journal":{"name":"Journal of immunological methods","volume":" ","pages":"113776"},"PeriodicalIF":1.6,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142648023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inducing and regulating human naive CD4+ t cell proliferation by different antigen presenting cells. 不同抗原提呈细胞诱导和调节人类幼稚 CD4+ t 细胞增殖。
IF 1.6 4区 医学 Q4 BIOCHEMICAL RESEARCH METHODS Pub Date : 2024-11-13 DOI: 10.1016/j.jim.2024.113775
Fabienne Mazerolles, Frédéric Rieux-Laucat

We have shown in previous studies that naive CD4+ T cells isolated from human peripheral blood are induced to proliferate by CD4negCD11c+CD14negCD16neg dendritic cells presenting the superantigen SEE. Since this population is very poorly expressed in blood, we tried to find other antigen presenting cells (APCs) to induce this proliferation. The aim of the previous studies was to investigate the regulation of T cell proliferation in pediatric monogenic autoimmune diseases and the regulation of this proliferation by regulatory T cells (TREGs). Since the blood samples from pediatric patients were very small, it was important to study other APCs that are more commonly present in the blood. In this study we tested different APCs isolated from controls, CD19+ B cells, CD11c+CD14+ and CD11c+CD14neg monocytes, CD11c+CD14negCD16+ and CD16neg dendritic cells. The different T cell populations, naive effector T cells and regulatory T cells were separated simultaneously from the same sample. We show in these studies that CD19+ B cells, CD14neg and more specifically CD14negCD16+, are also able to induce T cell proliferation as previously described with CD14negCD16neg DCs, but under different conditions. No proliferation was induced with CD14+ monocytes. However, these three APCs are less potent than CD16neg and inhibition by TREG is more difficult to detect. In addition, when we test the role of CTLA-4 in the regulation of TEFF proliferation, we observe that for some APCs, the inhibition by CTLA-4 was quite different. No inhibition was observed with CD19+ B cells in contrast to CD11c+CD14negCD16+ and CD11c+CD14negCD16neg .

我们在以前的研究中已经证明,从人类外周血中分离出来的幼稚 CD4+ T 细胞会被呈现超抗原 SEE 的 CD4negCD11c+CD14negCD16neg 树突状细胞诱导增殖。由于这一群体在血液中的表达量很低,我们试图寻找其他抗原呈递细胞(APC)来诱导这种增殖。之前研究的目的是调查小儿单基因自身免疫性疾病对 T 细胞增殖的调控以及调节性 T 细胞(TREGs)对这种增殖的调控。由于儿科患者的血液样本非常少,因此研究血液中更常见的其他 APCs 非常重要。在这项研究中,我们测试了从对照组、CD19+ B 细胞、CD11c+CD14+ 和 CD11c+CD14neg 单核细胞、CD11c+CD14negCD16+ 和 CD16neg 树突状细胞中分离出来的不同 APC。不同的 T 细胞群、幼稚效应 T 细胞和调节性 T 细胞同时从同一样本中分离出来。我们在这些研究中发现,CD19+ B 细胞、CD14neg,更具体地说是 CD14negCD16+,也能诱导 T 细胞增殖,就像之前用 CD14negCD16neg DCs 所描述的那样,但条件不同。CD14+ 单核细胞不能诱导 T 细胞增殖。不过,这三种 APC 的作用不如 CD16neg 强,而且 TREG 的抑制作用更难检测到。此外,当我们检测 CTLA-4 在 TEFF 增殖调控中的作用时,我们发现 CTLA-4 对某些 APC 的抑制作用大不相同。与 CD11c+CD14negCD16+ 和 CD11c+CD14negCD16neg 相反,CD19+ B 细胞没有抑制作用。
{"title":"Inducing and regulating human naive CD4<sup>+</sup> t cell proliferation by different antigen presenting cells.","authors":"Fabienne Mazerolles, Frédéric Rieux-Laucat","doi":"10.1016/j.jim.2024.113775","DOIUrl":"https://doi.org/10.1016/j.jim.2024.113775","url":null,"abstract":"<p><p>We have shown in previous studies that naive CD4<sup>+</sup> T cells isolated from human peripheral blood are induced to proliferate by CD4<sup>neg</sup>CD11c<sup>+</sup>CD14<sup>neg</sup>CD16<sup>neg</sup> dendritic cells presenting the superantigen SEE. Since this population is very poorly expressed in blood, we tried to find other antigen presenting cells (APCs) to induce this proliferation. The aim of the previous studies was to investigate the regulation of T cell proliferation in pediatric monogenic autoimmune diseases and the regulation of this proliferation by regulatory T cells (TREGs). Since the blood samples from pediatric patients were very small, it was important to study other APCs that are more commonly present in the blood. In this study we tested different APCs isolated from controls, CD19<sup>+</sup> B cells, CD11c<sup>+</sup>CD14<sup>+</sup> and CD11c<sup>+</sup>CD14<sup>neg</sup> monocytes, CD11c<sup>+</sup>CD14<sup>neg</sup>CD16<sup>+</sup> and CD16<sup>neg</sup> dendritic cells. The different T cell populations, naive effector T cells and regulatory T cells were separated simultaneously from the same sample. We show in these studies that CD19<sup>+</sup> B cells, CD14<sup>neg</sup> and more specifically CD14<sup>neg</sup>CD16<sup>+</sup>, are also able to induce T cell proliferation as previously described with CD14<sup>neg</sup>CD16<sup>neg</sup> DCs, but under different conditions. No proliferation was induced with CD14<sup>+</sup> monocytes. However, these three APCs are less potent than CD16<sup>neg</sup> and inhibition by TREG is more difficult to detect. In addition, when we test the role of CTLA-4 in the regulation of TEFF proliferation, we observe that for some APCs, the inhibition by CTLA-4 was quite different. No inhibition was observed with CD19<sup>+</sup> B cells in contrast to CD11c<sup>+</sup>CD14<sup>neg</sup>CD16<sup>+</sup> and CD11c<sup>+</sup>CD14<sup>neg</sup>CD16<sup>neg</sup> .</p>","PeriodicalId":16000,"journal":{"name":"Journal of immunological methods","volume":" ","pages":"113775"},"PeriodicalIF":1.6,"publicationDate":"2024-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142639145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A note of caution for using calmodulin antibodies 使用钙调蛋白抗体需谨慎。
IF 1.6 4区 医学 Q4 BIOCHEMICAL RESEARCH METHODS Pub Date : 2024-11-01 DOI: 10.1016/j.jim.2024.113772
Mads Munk, Martin W. Berchtold
Calmodulin (CaM) is a ubiquitous intracellular calcium receptor that regulates a plethora of cellular functions through interactions with target proteins. In mammals, an identical Calmodulin protein is expressed by 3 independent genes (CALM1, CALM2, CALM3). Therefore, antibodies generated against either of the three products (CaM1, CaM2, CaM3) of these genes cannot be distinguished, and conclusions based on the supposedly specific CaM antibodies claiming functions of one of the 3 genes may be misleading. In this paper we present 44 articles, using such antibodies for Western blot, ELISA assay, immunohistochemistry or which are based on proteomics and the use of databases with incorrect annotations, all potentially reaching misleading conclusions. This should be taken as a note of caution for researchers working with Calmodulin antibodies and misleading databases.
钙调蛋白(Calmodulin,CaM)是一种无处不在的细胞内钙受体,它通过与靶蛋白的相互作用来调节大量的细胞功能。在哺乳动物体内,相同的钙调素蛋白由 3 个独立基因(CALM1、CALM2 和 CALM3)表达。因此,针对这些基因的三种产物(CaM1、CaM2、CaM3)中的任何一种产生的抗体都无法区分,根据声称具有这三种基因之一功能的所谓特异性 CaM 抗体得出的结论可能会产生误导。在本文中,我们介绍了44篇文章,这些文章使用此类抗体进行Western印迹、ELISA检测、免疫组化,或基于蛋白质组学和使用注释不正确的数据库,所有这些都可能得出误导性结论。研究人员在使用钙调蛋白抗体和误导性数据库时应引以为戒。
{"title":"A note of caution for using calmodulin antibodies","authors":"Mads Munk,&nbsp;Martin W. Berchtold","doi":"10.1016/j.jim.2024.113772","DOIUrl":"10.1016/j.jim.2024.113772","url":null,"abstract":"<div><div>Calmodulin (CaM) is a ubiquitous intracellular calcium receptor that regulates a plethora of cellular functions through interactions with target proteins. In mammals, an identical Calmodulin protein is expressed by 3 independent genes (CALM1, CALM2, CALM3). Therefore, antibodies generated against either of the three products (CaM1, CaM2, CaM3) of these genes cannot be distinguished, and conclusions based on the supposedly specific CaM antibodies claiming functions of one of the 3 genes may be misleading. In this paper we present 44 articles, using such antibodies for Western blot, ELISA assay, immunohistochemistry or which are based on proteomics and the use of databases with incorrect annotations, all potentially reaching misleading conclusions. This should be taken as a note of caution for researchers working with Calmodulin antibodies and misleading databases.</div></div>","PeriodicalId":16000,"journal":{"name":"Journal of immunological methods","volume":"534 ","pages":"Article 113772"},"PeriodicalIF":1.6,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142567997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Generation and characterization of a monoclonal antibody Fab fragment targeting PBP2a in methicillin-resistant Staphylococcus aureus 针对耐甲氧西林金黄色葡萄球菌中 PBP2a 的单克隆抗体 Fab 片段的生成和特性分析。
IF 1.6 4区 医学 Q4 BIOCHEMICAL RESEARCH METHODS Pub Date : 2024-11-01 DOI: 10.1016/j.jim.2024.113774
Juliana Pascarelli Compan Boechat , Felipe Rodrigues Semcovici Ramos , Felipe Betoni Saraiva , Vinicius de Lima Gonçalves , Franklin Souza da Silva , Carlos Roberto Alves , José Procópio Moreno Senna , Haroldo Cid da Silva Júnior
Methicillin-resistant Staphylococcus aureus (MRSA) is one of the main pathogens associated with nosocomial and community infections that are difficult to treat owing to its resistance to all β-lactams and other classes of antibiotics. Reports of MRSA demonstrate the pathogen relevance and urgency for developing innovative diagnostic and treatment strategies against this microorganism. In this context, monoclonal antibodies (mAbs) represent a powerful tool for such purposes. Beta-lactam resistance in MRSA is caused by penicillin-binding protein 2a (PBP2a). The characteristics of PBP2a make this protein a potential target for immunobiologicals to combat this pathogen. This study describes the development of a recombinant Fab fragment from a mAb directed against the PBP2a protein, designed to identify and treat MRSA infections. The Fd and light chain coding sequences for Fab expression were amplified and ligated into the mammalian cell expression vector. Recombinant DNA constructs were used to transfect Expi293F cells expressing anti-PBP2a Fab. A purification based on ion-exchange chromatography was used for Fab separation, followed by analysis of antigen target recognition and interaction, either with the isolated antigen or with the antigen on the MRSA cell surface. The experimental approach allowed us to obtain significant Fab expression levels in the Expi293F system when transfecting the cells with the genetic constructs developed in pCDNA3.4 vector. Antigen target interaction assays revealed the capacity of Fab to recognize and interact with the PBP2a protein. Biodistribution analysis indicated serum Fab presence, in the serum, kidneys, lungs, and spleen, and a plasma half-life averaging 6–8 h.
耐甲氧西林金黄色葡萄球菌(MRSA)是与医院内和社区感染有关的主要病原体之一,由于其对β-内酰胺类和其他类抗生素具有耐药性,因此难以治疗。有关 MRSA 的报道表明,开发针对这种微生物的创新诊断和治疗策略具有病原体相关性和紧迫性。在这种情况下,单克隆抗体(mAbs)是一种强有力的工具。MRSA 的β-内酰胺耐药性是由青霉素结合蛋白 2a(PBP2a)引起的。PBP2a 的特性使其成为免疫生物制剂对付这种病原体的潜在靶标。本研究描述了一种针对 PBP2a 蛋白的 mAb 重组 Fab 片段的开发过程,旨在识别和治疗 MRSA 感染。用于表达 Fab 的 Fd 和轻链编码序列被扩增并连接到哺乳动物细胞表达载体中。重组 DNA 构建用于转染表达抗 PBP2a Fab 的 Expi293F 细胞。利用离子交换色谱纯化法分离 Fab,然后分析抗原靶标识别和与分离抗原或 MRSA 细胞表面抗原的相互作用。用 pCDNA3.4 载体开发的基因构建体转染 Expi293F 系统时,这种实验方法使我们能够在 Expi293F 系统中获得显著的 Fab 表达水平。抗原靶向相互作用测定显示,Fab 有能力识别 PBP2a 蛋白并与之相互作用。生物分布分析表明,血清、肾脏、肺部和脾脏中都存在 Fab,血浆半衰期平均为 6-8 小时。
{"title":"Generation and characterization of a monoclonal antibody Fab fragment targeting PBP2a in methicillin-resistant Staphylococcus aureus","authors":"Juliana Pascarelli Compan Boechat ,&nbsp;Felipe Rodrigues Semcovici Ramos ,&nbsp;Felipe Betoni Saraiva ,&nbsp;Vinicius de Lima Gonçalves ,&nbsp;Franklin Souza da Silva ,&nbsp;Carlos Roberto Alves ,&nbsp;José Procópio Moreno Senna ,&nbsp;Haroldo Cid da Silva Júnior","doi":"10.1016/j.jim.2024.113774","DOIUrl":"10.1016/j.jim.2024.113774","url":null,"abstract":"<div><div>Methicillin-resistant <em>Staphylococcus aureus</em> (MRSA) is one of the main pathogens associated with nosocomial and community infections that are difficult to treat owing to its resistance to all β-lactams and other classes of antibiotics. Reports of MRSA demonstrate the pathogen relevance and urgency for developing innovative diagnostic and treatment strategies against this microorganism. In this context, monoclonal antibodies (mAbs) represent a powerful tool for such purposes. Beta-lactam resistance in MRSA is caused by penicillin-binding protein 2a (PBP2a). The characteristics of PBP2a make this protein a potential target for immunobiologicals to combat this pathogen. This study describes the development of a recombinant Fab fragment from a mAb directed against the PBP2a protein, designed to identify and treat MRSA infections. The Fd and light chain coding sequences for Fab expression were amplified and ligated into the mammalian cell expression vector. Recombinant DNA constructs were used to transfect Expi293F cells expressing anti-PBP2a Fab. A purification based on ion-exchange chromatography was used for Fab separation, followed by analysis of antigen target recognition and interaction, either with the isolated antigen or with the antigen on the MRSA cell surface. The experimental approach allowed us to obtain significant Fab expression levels in the Expi293F system when transfecting the cells with the genetic constructs developed in pCDNA3.4 vector. Antigen target interaction assays revealed the capacity of Fab to recognize and interact with the PBP2a protein. Biodistribution analysis indicated serum Fab presence, in the serum, kidneys, lungs, and spleen, and a plasma half-life averaging 6–8 h.</div></div>","PeriodicalId":16000,"journal":{"name":"Journal of immunological methods","volume":"534 ","pages":"Article 113774"},"PeriodicalIF":1.6,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142621924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Workflow improvement and financial gain after integration of high-throughput sample processing system with flow cytometer in a high-volume pathology laboratory: Results from a prospective comparative study using Lean principles 大容量病理实验室将高通量样本处理系统与流式细胞仪整合后的工作流程改进和财务收益:利用精益原则进行前瞻性比较研究的结果。
IF 1.6 4区 医学 Q4 BIOCHEMICAL RESEARCH METHODS Pub Date : 2024-11-01 DOI: 10.1016/j.jim.2024.113767
Debbie Bruno , Cathy du Plessis , Cathy von Rooyen , Shafiq Abdallah , Bilal Abdallah , Erik P. Erdal , Lori Apoll

Background

Highly efficient clinical laboratories are essential for monitoring many human illnesses. Ampath Laboratory Services, the largest pathology lab in South Africa, analyzes large numbers of peripheral blood samples for CD4 levels yearly.

Objective

To assess productivity and quality of a newer integrated automated solution, the BD FACSDuet™ Sample Preparation System/BD FACSLyric™ Flow Cytometer using conventional assessment methods and Lean concepts.

Materials and methods

This prospective study compared the performance of the BD FACS™ Sample Preparation Assistant [SPA] III and BD FACSCanto™ II Flow Cytometer with the newly introduced integrated system (BD FACSDuet™/BD FACSLyric™). They were validated for accuracy, precision, and external quality assessment. Process mapping and Lean assessment helped identify steps leading to waste. An economic model was developed to characterize workflow and economic impact associated with total daily hands-on time, processing time, and reworks.

Results

Strong linear correlation was present between both systems. Precision and accuracy studies revealed that all coefficient of variation (CV)% values were below 20% of allowable limits. External proficiency assessments were within limits. The fully automated workflow of BD FACSDuet™/BD FACSLyric™ permitted better consistency with significantly shorter processing time and batch processing and reduced operator interventions. Lean assessment identified defects with motion, over-processing, waiting, and non-utilized talent. Significant reductions in hands-on and total daily processing time that could increase daily specimen testing efficiency and fewer reworks were associated with the BD FACSDuet™/BD FACSLyric™. Lean improvements translated to significant economic savings associated with operator costs and unnecessary reagent consumption.

Conclusion

BD FACSDuet™/BD FACSLyric™ is an accurate, reliable, and cost-effective fully automated system for high-volume flow cytometry labs that perform T-cell enumeration using a single-platform and single-tube approach.
背景:高效的临床实验室对于监测许多人类疾病至关重要。Ampath Laboratory Services 是南非最大的病理实验室,每年都要对大量外周血样本进行 CD4 水平分析:采用传统评估方法和精益理念,评估较新的集成自动化解决方案(BD FACSDuet™ 样品制备系统/BD FACSLyric™ 流式细胞仪)的生产率和质量:这项前瞻性研究比较了 BD FACS™ Sample Preparation Assistant [SPA] III 和 BD FACSCanto™ II 流式细胞仪与新引进的集成系统(BD FACSDuet™/BD FACSLyric™)的性能。它们在准确度、精确度和外部质量评估方面都得到了验证。流程制图和精益评估有助于确定导致浪费的步骤。建立了一个经济模型来描述工作流程以及与每日总动手时间、处理时间和返工相关的经济影响:结果:两个系统之间存在很强的线性相关。精确度和准确度研究表明,所有变异系数 (CV) % 值均低于允许限度的 20%。外部能力评估也在允许范围内。BD FACSDuet™/BD FACSLyric™ 的全自动工作流程大大缩短了处理时间和批量处理时间,减少了操作员的干预,从而提高了一致性。精益评估发现了运动、过度处理、等待和未利用人才等缺陷。BD FACSDuet™/BD FACSLyric™ 显著减少了操作时间和每日总处理时间,从而提高了每日标本检测效率,减少了返工。精益生产的改进大大节省了操作成本和不必要的试剂消耗:BD FACSDuet™/BD FACSLyric™ 是一种准确、可靠、经济高效的全自动系统,适用于采用单平台、单试管方法进行 T 细胞计数的大批量流式细胞仪实验室。
{"title":"Workflow improvement and financial gain after integration of high-throughput sample processing system with flow cytometer in a high-volume pathology laboratory: Results from a prospective comparative study using Lean principles","authors":"Debbie Bruno ,&nbsp;Cathy du Plessis ,&nbsp;Cathy von Rooyen ,&nbsp;Shafiq Abdallah ,&nbsp;Bilal Abdallah ,&nbsp;Erik P. Erdal ,&nbsp;Lori Apoll","doi":"10.1016/j.jim.2024.113767","DOIUrl":"10.1016/j.jim.2024.113767","url":null,"abstract":"<div><h3>Background</h3><div>Highly efficient clinical laboratories are essential for monitoring many human illnesses. Ampath Laboratory Services, the largest pathology lab in South Africa, analyzes large numbers of peripheral blood samples for CD4 levels yearly.</div></div><div><h3>Objective</h3><div>To assess productivity and quality of a newer integrated automated solution, the BD FACSDuet™ Sample Preparation System/BD FACSLyric™ Flow Cytometer using conventional assessment methods and Lean concepts.</div></div><div><h3>Materials and methods</h3><div>This prospective study compared the performance of the BD FACS™ Sample Preparation Assistant [SPA] III and BD FACSCanto™ II Flow Cytometer with the newly introduced integrated system (BD FACSDuet™/BD FACSLyric™). They were validated for accuracy, precision, and external quality assessment. Process mapping and Lean assessment helped identify steps leading to waste. An economic model was developed to characterize workflow and economic impact associated with total daily hands-on time, processing time, and reworks.</div></div><div><h3>Results</h3><div>Strong linear correlation was present between both systems. Precision and accuracy studies revealed that all coefficient of variation (CV)% values were below 20% of allowable limits. External proficiency assessments were within limits. The fully automated workflow of BD FACSDuet™/BD FACSLyric™ permitted better consistency with significantly shorter processing time and batch processing and reduced operator interventions. Lean assessment identified defects with motion, over-processing, waiting, and non-utilized talent. Significant reductions in hands-on and total daily processing time that could increase daily specimen testing efficiency and fewer reworks were associated with the BD FACSDuet™/BD FACSLyric™. Lean improvements translated to significant economic savings associated with operator costs and unnecessary reagent consumption.</div></div><div><h3>Conclusion</h3><div>BD FACSDuet™/BD FACSLyric™ is an accurate, reliable, and cost-effective fully automated system for high-volume flow cytometry labs that perform T-cell enumeration using a single-platform and single-tube approach.</div></div>","PeriodicalId":16000,"journal":{"name":"Journal of immunological methods","volume":"534 ","pages":"Article 113767"},"PeriodicalIF":1.6,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142467508","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epitope profiling of cow's milk allergen-specific antibodies with determining IgE content in epitopes-ALL, a 14-epitopes mixture. 牛乳过敏原特异性抗体表位谱分析,确定表位谱-ALL(14 个表位谱混合物)中的 IgE 含量。
IF 1.6 4区 医学 Q4 BIOCHEMICAL RESEARCH METHODS Pub Date : 2024-11-01 DOI: 10.1016/j.jim.2024.113773
Yoshihiro Watanabe, Ikuo Okafuji, Satoko Tamai, Natsuko Hosokawa, Takako Ohbayashi, Shigeki Kato, Kiyoaki Ito, Mitsuhiro Kawano, Yusei Ohshima

Allergen-specific antibodies (Abs), IgE, and IgG4 increase during the early phase of oral immunotherapy (OIT) of allergen food in patients; subsequently, IgE levels decrease and specific IgG4 levels increase after successful OIT treatment. The detailed profile of these Abs during OIT remains largely unclear. We developed a diagnostic tool to assess the OIT efficacy and extent of responsiveness based on a profiling method by identifying epitopes recognized by the Ab classes of IgE or IgG4. A peptide microarray followed by microplate analysis using synthetic peptides was used to identify 14 epitopes widely recognized by IgE and/or IgG4 in the serum samples of patients with OIT among the amino acid sequences of five major cow's milk allergens. The set of defined 14 epitopes clarified different epitope profiles of allergen-specific IgE and IgG4 in each patient's serum samples. Moreover, the total signal of Abs recognizing all 14 epitopes was equal to the sum of all individual epitope-specific Abs. It was further observed that the quantitative value of IgE concentrations of 14 epitopes-ALL correlated with the ImmunoCAP IgE value. These findings strongly imply that the quantity of IgE and IgG4 recognizing epitopes-ALL may easily be used to measure allergy severity. To investigate this potential, we developed an immunochromatographic method that can detect IgE and IgG4 levels in patient samples. This study clearly demonstrated the usefulness of the defined 14 epitopes and their mixture, "epitopes-ALL," and that the simple and reliable methods of immunochromatography and microplate analyses demonstrating the epitope profile of allergen-specific Abs are applicable for diagnostic use at multiple disease stages and the OIT-treatment course in patients with cow's milk allergy.

过敏原特异性抗体(Abs)、IgE 和 IgG4 在患者口服过敏原食物免疫疗法(OIT)的早期阶段会增加;随后,在 OIT 治疗成功后,IgE 水平会降低,特异性 IgG4 水平会增加。OIT 期间这些 Abs 的详细情况在很大程度上仍不清楚。我们开发了一种诊断工具,通过识别 IgE 或 IgG4 类抗体识别的表位,以剖析法为基础评估 OIT 的疗效和反应程度。在使用合成肽进行微孔板分析后,我们使用肽芯片从五种主要牛奶过敏原的氨基酸序列中识别出了 OIT 患者血清样本中 IgE 和/或 IgG4 广泛识别的 14 个表位。这 14 个表位明确了每位患者血清样本中过敏原特异性 IgE 和 IgG4 的不同表位特征。此外,识别所有 14 个表位的抗体的总信号等于所有单个表位特异性抗体的总和。进一步观察发现,14 个表位-ALL 的 IgE 浓度定量值与 ImmunoCAP IgE 值相关。这些发现有力地表明,识别表位-ALL 的 IgE 和 IgG4 的数量很容易用来衡量过敏的严重程度。为了研究这一潜力,我们开发了一种免疫层析方法,可以检测患者样本中的 IgE 和 IgG4 水平。这项研究清楚地证明了已定义的 14 个表位及其混合物 "表位-ALL "的实用性,而且证明过敏原特异性 Abs 表位谱的免疫层析法和微孔板分析法简单可靠,可用于牛奶过敏患者多个疾病阶段和 OIT 治疗过程的诊断。
{"title":"Epitope profiling of cow's milk allergen-specific antibodies with determining IgE content in epitopes-ALL, a 14-epitopes mixture.","authors":"Yoshihiro Watanabe, Ikuo Okafuji, Satoko Tamai, Natsuko Hosokawa, Takako Ohbayashi, Shigeki Kato, Kiyoaki Ito, Mitsuhiro Kawano, Yusei Ohshima","doi":"10.1016/j.jim.2024.113773","DOIUrl":"https://doi.org/10.1016/j.jim.2024.113773","url":null,"abstract":"<p><p>Allergen-specific antibodies (Abs), IgE, and IgG4 increase during the early phase of oral immunotherapy (OIT) of allergen food in patients; subsequently, IgE levels decrease and specific IgG4 levels increase after successful OIT treatment. The detailed profile of these Abs during OIT remains largely unclear. We developed a diagnostic tool to assess the OIT efficacy and extent of responsiveness based on a profiling method by identifying epitopes recognized by the Ab classes of IgE or IgG4. A peptide microarray followed by microplate analysis using synthetic peptides was used to identify 14 epitopes widely recognized by IgE and/or IgG4 in the serum samples of patients with OIT among the amino acid sequences of five major cow's milk allergens. The set of defined 14 epitopes clarified different epitope profiles of allergen-specific IgE and IgG4 in each patient's serum samples. Moreover, the total signal of Abs recognizing all 14 epitopes was equal to the sum of all individual epitope-specific Abs. It was further observed that the quantitative value of IgE concentrations of 14 epitopes-ALL correlated with the ImmunoCAP IgE value. These findings strongly imply that the quantity of IgE and IgG4 recognizing epitopes-ALL may easily be used to measure allergy severity. To investigate this potential, we developed an immunochromatographic method that can detect IgE and IgG4 levels in patient samples. This study clearly demonstrated the usefulness of the defined 14 epitopes and their mixture, \"epitopes-ALL,\" and that the simple and reliable methods of immunochromatography and microplate analyses demonstrating the epitope profile of allergen-specific Abs are applicable for diagnostic use at multiple disease stages and the OIT-treatment course in patients with cow's milk allergy.</p>","PeriodicalId":16000,"journal":{"name":"Journal of immunological methods","volume":" ","pages":"113773"},"PeriodicalIF":1.6,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142568170","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of an ELISA for an effective potency determination of recombinant rabies human monoclonal antibody 开发一种有效测定重组狂犬病人类单克隆抗体效价的酶联免疫吸附试验。
IF 1.6 4区 医学 Q4 BIOCHEMICAL RESEARCH METHODS Pub Date : 2024-11-01 DOI: 10.1016/j.jim.2024.113769
Ambika Divase , Sambhaji Pisal , Manjusha Dake , Rajeev Dhere , Pravin Kumar Dakshinamurthy , Peddireddy Srinivas Reddy , Chandrashekhar Kamat , Digamber Singh Chahar , Jayanta Pal , Neelu Nawani
Rapid Fluorescence Focus Inhibition Test (RFFIT) is the most widely used cell-based assay to measure the potency of recombinant human rabies monoclonal antibodies. Nonetheless, RFFIT assay is time-consuming and it requires well-equipped biosafety level 2 facility, virulent live rabies virus cultures, permissive cell lines, and well-trained manpower. Therefore, the development of alternative methods to the RFFIT has been encouraged by the World Health Organization (WHO) expert working groups to overcome these barriers.
An In-vitro ELISA test has been developed as an alternative to the RFFIT assay, for quantifying the rabies monoclonal antibody (mAb) potency using inactivated rabies virus vaccine (Rabivax-S). It is based on the specific interaction between the antigen and the antibody, that induces neutralizing antibody response to rabies virus.
The ELISA was validated involving accuracy and precision within 20 % coefficient of variance. The validation has been done by 4PL standard curve with linearity r2 ˃ 0.98 and LLOQ of 0.3 μg/mL indicating high assay sensitivity. The specificity of the assay was ascertained by challenging with another homologous non-rabies humanized mAb, which does not show binding with the rabies virus.
The indirect ELISA developed here, is precise, robust, and accurate to quantitate the potency of rabies monoclonal antibody. It is highly sensitive and has a broad range of detection. It is easy to perform, and it has a short turnaround time (results available in few hours). Furthermore, it is cost effective and can be performed with low-cost resource setting, as there is no requirement of handling the live cells and live virus and also BSL-2 Facility.
快速荧光聚焦抑制试验(RFFIT)是最广泛使用的基于细胞的检测方法,用于测量重组人狂犬病单克隆抗体的效力。然而,快速荧光聚焦抑制试验非常耗时,而且需要设备齐全的 2 级生物安全设施、活狂犬病毒毒力培养物、许可细胞系和训练有素的人员。因此,世界卫生组织(WHO)专家工作组鼓励开发 RFFIT 的替代方法,以克服这些障碍。目前已开发出一种体外 ELISA 检测法,作为 RFFIT 检测法的替代方法,利用灭活狂犬病毒疫苗 (Rabivax-S) 量化狂犬病单克隆抗体 (mAb) 的效力。该方法基于抗原与抗体之间的特异性相互作用,可诱导狂犬病病毒中和抗体反应。酶联免疫吸附试验的准确度和精密度在 20% 的方差系数范围内。通过 4PL 标准曲线进行了验证,线性关系 r2 ˃ o.98,LLOQ 为 0.3 μg/mL,表明检测灵敏度很高。通过与另一种同源的非狂犬病人源化 mAb 进行比对,确定了该检测方法的特异性。在此开发的间接 ELISA 能精确、稳健、准确地量化狂犬病单克隆抗体的效价。它灵敏度高,检测范围广。它易于操作,周转时间短(几小时内即可得到结果)。此外,由于不需要处理活细胞和活病毒,也不需要 BSL-2 设施,因此成本效益高,可在低成本资源设置下进行。
{"title":"Development of an ELISA for an effective potency determination of recombinant rabies human monoclonal antibody","authors":"Ambika Divase ,&nbsp;Sambhaji Pisal ,&nbsp;Manjusha Dake ,&nbsp;Rajeev Dhere ,&nbsp;Pravin Kumar Dakshinamurthy ,&nbsp;Peddireddy Srinivas Reddy ,&nbsp;Chandrashekhar Kamat ,&nbsp;Digamber Singh Chahar ,&nbsp;Jayanta Pal ,&nbsp;Neelu Nawani","doi":"10.1016/j.jim.2024.113769","DOIUrl":"10.1016/j.jim.2024.113769","url":null,"abstract":"<div><div>Rapid Fluorescence Focus Inhibition Test (RFFIT) is the most widely used cell-based assay to measure the potency of recombinant human rabies monoclonal antibodies. Nonetheless, RFFIT assay is time-consuming and it requires well-equipped biosafety level 2 facility, virulent live rabies virus cultures, permissive cell lines, and well-trained manpower. Therefore, the development of alternative methods to the RFFIT has been encouraged by the World Health Organization (WHO) expert working groups to overcome these barriers.</div><div>An <em>In-vitro</em> ELISA test has been developed as an alternative to the RFFIT assay, for quantifying the rabies monoclonal antibody (mAb) potency using inactivated rabies virus vaccine (Rabivax-S). It is based on the specific interaction between the antigen and the antibody, that induces neutralizing antibody response to rabies virus.</div><div>The ELISA was validated involving accuracy and precision within 20 % coefficient of variance. The validation has been done by 4PL standard curve with linearity r<sup>2</sup> ˃ 0.98 and LLOQ of 0.3 μg/mL indicating high assay sensitivity. The specificity of the assay was ascertained by challenging with another homologous non-rabies humanized mAb, which does not show binding with the rabies virus.</div><div>The indirect ELISA developed here, is precise, robust, and accurate to quantitate the potency of rabies monoclonal antibody. It is highly sensitive and has a broad range of detection. It is easy to perform, and it has a short turnaround time (results available in few hours). Furthermore, it is cost effective and can be performed with low-cost resource setting, as there is no requirement of handling the live cells and live virus and also BSL-2 Facility.</div></div>","PeriodicalId":16000,"journal":{"name":"Journal of immunological methods","volume":"534 ","pages":"Article 113769"},"PeriodicalIF":1.6,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142502036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of a novel and broadly applicable sandwich ELISA assay based on rabbit single-chain variable fragments and a modified Ig-binding domain of protein L fused to a polystyrene-binding peptide 基于兔单链可变片段和与聚苯乙烯结合肽融合的蛋白 L 的改良 Ig 结合域,开发出一种新型的、可广泛应用的夹心酶联免疫吸附测定法。
IF 1.6 4区 医学 Q4 BIOCHEMICAL RESEARCH METHODS Pub Date : 2024-11-01 DOI: 10.1016/j.jim.2024.113771
Yodai Yamamoto , Haruka Taniguchi , Ngoc Minh Nguyen , Fuki Yokoyama , Kiattawee Choowongkomon , Alessandro Angelini , Jun-Ichi Horiuchi , Yoichi Kumada
Most of currently available sandwich-type enzyme-linked immunosorbent assays (ELISA) require the use of full-length animal-derived antibodies which poses welfare criticisms and are often expensive to produce. There is therefore a strong demand for the development of more affordable and animal-free methods to produce antibodies for sandwich ELISA assay. To address these issues, we propose here the development of a new technology based on two complementary rabbit single-chain variable fragments (scFvs) and an Ig-binding domain of protein L (PpL1) fused to a polystyrene-binding peptide (PS-tag) that can be recombinantly produced in bacteria. Toward this goal, we developed a rabbit scFv capable to bind the antigen via its variable regions while engaging protein L through its constant framework domain. To enhance the density of captured scFv and enable a better solvent exposure, we generated multiple PpL1 variants bearing polystyrene-binding peptides (PS) tags fused to its ends. The tandem trimer of PpL1 variant bearing PS-tags located at the N-terminus (PpL1′-T-PSN) revealed increased antigen-binding signal when immobilized on hydrophilic polystyrene (phi-PS) plates. By CDR-grafting different antigen-binding specificities into our engineered protein L-binding scFv we validated our technology against a different antigen. Finally, to further enhance the sensitivity of our assay, we implemented a protein L-based pretreatment to remove potential inhibitory immunoglobulin often present in the blood samples. The ability to rapidly and cost-effectively generate animal-free recombinant antibody fragments that can be adsorbed and specifically oriented on plates while retaining their antigen-binding properties could lead to the development of innovative and widely applicable sandwich ELISA systems for the efficient, versatile and sensitive detection of different types of antigens.
目前,大多数夹心酶联免疫吸附测定法(ELISA)都需要使用全长的动物源抗体,这不仅会带来福利问题,而且生产成本往往很高。因此,人们强烈要求开发更经济实惠且不使用动物的方法来生产用于夹心酶联免疫吸附测定的抗体。为了解决这些问题,我们在此提议开发一种新技术,该技术基于两个互补的兔单链可变片段(scFvs)和一个融合了聚苯乙烯结合肽(PS-tag)的蛋白质 L(PpL1)的 Ig 结合域,可在细菌中重组生产。为了实现这一目标,我们开发了一种兔 scFv,它能通过其可变区与抗原结合,同时通过其恒定框架域与蛋白 L 结合。为了提高捕获 scFv 的密度并使其更好地暴露于溶剂中,我们生成了多个 PpL1 变体,其末端融合了聚苯乙烯结合肽(PS)标签。当固定在亲水性聚苯乙烯(phi-PS)板上时,在 N 端带有 PS 标记的串联三聚体 PpL1 变体(PpL1'-T-PSN)显示出更强的抗原结合信号。通过将不同的抗原结合特异性 CDR 嫁接到我们设计的蛋白 L 结合 scFv 中,我们针对不同的抗原验证了我们的技术。最后,为了进一步提高检测灵敏度,我们采用了基于蛋白 L 的预处理方法,以去除血液样本中常见的潜在抑制性免疫球蛋白。快速、低成本地生成不含动物成分的重组抗体片段的能力,可以吸附并特异性地定向在平板上,同时保持其抗原结合特性,从而开发出创新的、可广泛应用的夹心 ELISA 系统,用于高效、多用途、灵敏地检测不同类型的抗原。
{"title":"Development of a novel and broadly applicable sandwich ELISA assay based on rabbit single-chain variable fragments and a modified Ig-binding domain of protein L fused to a polystyrene-binding peptide","authors":"Yodai Yamamoto ,&nbsp;Haruka Taniguchi ,&nbsp;Ngoc Minh Nguyen ,&nbsp;Fuki Yokoyama ,&nbsp;Kiattawee Choowongkomon ,&nbsp;Alessandro Angelini ,&nbsp;Jun-Ichi Horiuchi ,&nbsp;Yoichi Kumada","doi":"10.1016/j.jim.2024.113771","DOIUrl":"10.1016/j.jim.2024.113771","url":null,"abstract":"<div><div>Most of currently available sandwich-type enzyme-linked immunosorbent assays (ELISA) require the use of full-length animal-derived antibodies which poses welfare criticisms and are often expensive to produce. There is therefore a strong demand for the development of more affordable and animal-free methods to produce antibodies for sandwich ELISA assay. To address these issues, we propose here the development of a new technology based on two complementary rabbit single-chain variable fragments (scFvs) and an Ig-binding domain of protein L (PpL1) fused to a polystyrene-binding peptide (PS-tag) that can be recombinantly produced in bacteria. Toward this goal, we developed a rabbit scFv capable to bind the antigen via its variable regions while engaging protein L through its constant framework domain. To enhance the density of captured scFv and enable a better solvent exposure, we generated multiple PpL1 variants bearing polystyrene-binding peptides (PS) tags fused to its ends. The tandem trimer of PpL1 variant bearing PS-tags located at the N-terminus (PpL1′-T-PSN) revealed increased antigen-binding signal when immobilized on hydrophilic polystyrene (phi-PS) plates. By CDR-grafting different antigen-binding specificities into our engineered protein L-binding scFv we validated our technology against a different antigen. Finally, to further enhance the sensitivity of our assay, we implemented a protein L-based pretreatment to remove potential inhibitory immunoglobulin often present in the blood samples. The ability to rapidly and cost-effectively generate animal-free recombinant antibody fragments that can be adsorbed and specifically oriented on plates while retaining their antigen-binding properties could lead to the development of innovative and widely applicable sandwich ELISA systems for the efficient, versatile and sensitive detection of different types of antigens.</div></div>","PeriodicalId":16000,"journal":{"name":"Journal of immunological methods","volume":"534 ","pages":"Article 113771"},"PeriodicalIF":1.6,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142568110","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Decreased variability in the site-specific results during participation in the External Quality Assurance Program Oversight Laboratory (EQAPOL) proficiency program for IFN-gamma enzyme-linked immunospot (IFN-γ ELISpot) assay 在参加外部质量保证计划监督实验室(EQAPOL)IFN-γ 酶联免疫斑点(IFN-γ ELISpot)检测能力验证计划期间,降低了检测点特定结果的变异性。
IF 1.6 4区 医学 Q4 BIOCHEMICAL RESEARCH METHODS Pub Date : 2024-10-23 DOI: 10.1016/j.jim.2024.113770
Paul M. Hargarten , Cassandra G. Porth , Mark Berrong , Darin Weed , Miranda Carper , Thomas N. Denny , Guido Ferrari , Wes Rountree
The NIAID DAIDS-sponsored External Quality Assurance Program Oversight Laboratory (EQAPOL) manages an interferon-gamma (IFN-γ) enzyme-linked immunospot (ELISpot) external proficiency program. The ELISpot program evaluates the accuracy and variability of results across laboratories. The variability in the program is quantified via the dispersion, which is the ratio of the variance over the mean of the background-corrected spot-forming cells (SFC) replicates obtained under stimulation with different peptide pools (CMV, CEF). This report includes the longitudinal analysis of the ELISpot program cohort composed of 22 laboratories from 2011 to 2022 to assess whether the within-lab variability has improved over time. Random intercept models of the dispersion over time showed a significant decrease in overall dispersion from an average of approximately 1.8 in 2011 to approximately 1.25 in 2022. Out of the 21 sites, 16 sites (4 being statistically significant) had a negative trend for dispersion over time. Our finding of a reduction of overall within-lab variability demonstrates the need for and benefit of proficiency testing programs.
NIAID DAIDS 赞助的外部质量保证计划监督实验室 (EQAPOL) 负责管理干扰素-γ (IFN-γ) 酶联免疫斑点 (ELISpot) 外部能力验证计划。ELISpot 计划评估各实验室检测结果的准确性和变异性。该计划中的变异性通过离散度进行量化,离散度是在不同肽池(CMV、CEF)刺激下获得的经背景校正的斑点形成细胞(SFC)复制的方差与平均值之比。本报告包括对2011年至2022年由22个实验室组成的ELISpot计划队列的纵向分析,以评估实验室内的变异性是否随着时间的推移而改善。随机截距模型显示,随着时间的推移,总体离散度明显下降,从2011年的平均约1.8下降到2022年的约1.25。在 21 个观测点中,16 个观测点(4 个具有显著统计学意义)的离散度随时间呈负值趋势。我们发现,实验室内部的总体变异性有所降低,这表明能力验证计划是必要的,也是有益的。
{"title":"Decreased variability in the site-specific results during participation in the External Quality Assurance Program Oversight Laboratory (EQAPOL) proficiency program for IFN-gamma enzyme-linked immunospot (IFN-γ ELISpot) assay","authors":"Paul M. Hargarten ,&nbsp;Cassandra G. Porth ,&nbsp;Mark Berrong ,&nbsp;Darin Weed ,&nbsp;Miranda Carper ,&nbsp;Thomas N. Denny ,&nbsp;Guido Ferrari ,&nbsp;Wes Rountree","doi":"10.1016/j.jim.2024.113770","DOIUrl":"10.1016/j.jim.2024.113770","url":null,"abstract":"<div><div>The NIAID DAIDS-sponsored External Quality Assurance Program Oversight Laboratory (EQAPOL) manages an interferon-gamma (IFN-γ) enzyme-linked immunospot (ELISpot) external proficiency program. The ELISpot program evaluates the accuracy and variability of results across laboratories. The variability in the program is quantified via the dispersion, which is the ratio of the variance over the mean of the background-corrected spot-forming cells (SFC) replicates obtained under stimulation with different peptide pools (CMV, CEF). This report includes the longitudinal analysis of the ELISpot program cohort composed of 22 laboratories from 2011 to 2022 to assess whether the within-lab variability has improved over time. Random intercept models of the dispersion over time showed a significant decrease in overall dispersion from an average of approximately 1.8 in 2011 to approximately 1.25 in 2022. Out of the 21 sites, 16 sites (4 being statistically significant) had a negative trend for dispersion over time. Our finding of a reduction of overall within-lab variability demonstrates the need for and benefit of proficiency testing programs.</div></div>","PeriodicalId":16000,"journal":{"name":"Journal of immunological methods","volume":"534 ","pages":"Article 113770"},"PeriodicalIF":1.6,"publicationDate":"2024-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142502035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Human monoclonal antibody cloning and expression with overlap extension PCR and short DNA fragments 利用重叠延伸 PCR 和短 DNA 片段克隆和表达人类单克隆抗体。
IF 1.6 4区 医学 Q4 BIOCHEMICAL RESEARCH METHODS Pub Date : 2024-10-22 DOI: 10.1016/j.jim.2024.113768
Zachary Ende , Margarita Mishina , Robert C. Kauffman , Amrita Kumar , Rashmi Kumari , Paul R. Knight , Suryaprakash Sambhara
Monoclonal antibodies are powerful therapeutic, diagnostic, and research tools. Methods utilized to generate monoclonal antibodies are evolving rapidly. We created a transfectable linear antibody expression cassette from a 2-h high-fidelity overlapping PCR reaction from synthesized DNA fragments. We coupled heavy and light chains into a single linear sequence with a promoter, self-cleaving peptide, and poly(A) signal to increase the flexibility of swapping variable regions from any sequence available in silico. Transfection of the linear cassette tended to generate similar levels to the two-plasmid system and generated an average of 47 μg (14–98 μg) after 5 days in 2 ml cultures with 15 unique antibody sequences. The levels of antibodies produced were sufficient for most downstream applications in less than a week. The method presented here reduces the time, cost, and complexity of cloning steps.
单克隆抗体是强大的治疗、诊断和研究工具。生成单克隆抗体的方法发展迅速。我们利用合成的 DNA 片段,通过 2 小时的高保真重叠 PCR 反应创建了可转染的线性抗体表达盒。我们将重链和轻链与启动子、自裂肽和聚(A)信号耦合到一个线性序列中,以增加从任何可用序列中交换可变区的灵活性。线性盒转染产生的抗体水平与双质粒系统相似,在 2 毫升培养基中培养 5 天后,平均产生 47 微克(14-98 微克)的 15 种独特抗体序列。在不到一周的时间内,所产生的抗体水平足以满足大多数下游应用的需要。这里介绍的方法减少了克隆步骤的时间、成本和复杂性。
{"title":"Human monoclonal antibody cloning and expression with overlap extension PCR and short DNA fragments","authors":"Zachary Ende ,&nbsp;Margarita Mishina ,&nbsp;Robert C. Kauffman ,&nbsp;Amrita Kumar ,&nbsp;Rashmi Kumari ,&nbsp;Paul R. Knight ,&nbsp;Suryaprakash Sambhara","doi":"10.1016/j.jim.2024.113768","DOIUrl":"10.1016/j.jim.2024.113768","url":null,"abstract":"<div><div>Monoclonal antibodies are powerful therapeutic, diagnostic, and research tools. Methods utilized to generate monoclonal antibodies are evolving rapidly. We created a transfectable linear antibody expression cassette from a 2-h high-fidelity overlapping PCR reaction from synthesized DNA fragments. We coupled heavy and light chains into a single linear sequence with a promoter, self-cleaving peptide, and poly(A) signal to increase the flexibility of swapping variable regions from any sequence available <em>in silico</em>. Transfection of the linear cassette tended to generate similar levels to the two-plasmid system and generated an average of 47 μg (14–98 μg) after 5 days in 2 ml cultures with 15 unique antibody sequences. The levels of antibodies produced were sufficient for most downstream applications in less than a week. The method presented here reduces the time, cost, and complexity of cloning steps.</div></div>","PeriodicalId":16000,"journal":{"name":"Journal of immunological methods","volume":"534 ","pages":"Article 113768"},"PeriodicalIF":1.6,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142502037","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of immunological methods
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1